ALPS Advisors’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-30,416
| Closed | -$3.14M | – | 1028 |
|
|
2022
Q3 | $3.14M | Sell |
30,416
-214
| -0.7% | -$22.1K | 0.03% | 216 |
|
|
2022
Q2 | $2.85M | Buy |
+30,630
| New | +$2.85M | 0.03% | 245 |
|
|
2019
Q2 | – | Sell |
-70,468
| Closed | -$8.29M | – | 880 |
|
|
2019
Q1 | $8.29M | Sell |
70,468
-26,667
| -27% | -$3.14M | 0.06% | 132 |
|
|
2018
Q4 | $6.09M | Buy |
97,135
+31,687
| +48% | +$1.99M | 0.05% | 139 |
|
|
2018
Q3 | $4.64M | Buy |
65,448
+12,124
| +23% | +$859K | 0.03% | 168 |
|
|
2018
Q2 | $3.55M | Buy |
53,324
+4,549
| +9% | +$303K | 0.02% | 194 |
|
|
2018
Q1 | $3.19M | Buy |
48,775
+8,478
| +21% | +$554K | 0.03% | 175 |
|
|
2017
Q4 | $1.61M | Buy |
40,297
+8,368
| +26% | +$335K | 0.01% | 209 |
|
|
2017
Q3 | $1.16M | Buy |
31,929
+2,665
| +9% | +$96.6K | 0.01% | 231 |
|
|
2017
Q2 | $812K | Buy |
29,264
+2,144
| +8% | +$59.5K | 0.01% | 261 |
|
|
2017
Q1 | $759K | Sell |
27,120
-3,176
| -10% | -$88.9K | 0.01% | 244 |
|
|
2016
Q4 | $613K | Buy |
+30,296
| New | +$613K | ﹤0.01% | 267 |
|
|
2016
Q2 | – | Sell |
-28,259
| Closed | -$524K | – | 611 |
|
|
2016
Q1 | $524K | Sell |
28,259
-4,843
| -15% | -$89.8K | 0.01% | 212 |
|
|
2015
Q4 | $606K | Sell |
33,102
-4,208
| -11% | -$77K | 0.01% | 265 |
|
|
2015
Q3 | $6.6K | Buy |
37,310
+13,684
| +58% | +$2.42K | 0.01% | 237 |
|
|
2015
Q2 | $415K | Buy |
+23,626
| New | +$415K | ﹤0.01% | 623 |
|